 vitro cultivation Cryptosporidium parvum screening anticryptosporidial drugs Sporozoites Cryptosporidium parvum vitro oocysts calves patients immune deficiency underwent development monolayers mouse fibroblast cell line Asexual multiplication maximum numbers parasites infection Gametocytes numbers small asexual stages study effect parasite development antimicrobial agents anticoccidial antimalarial agents majority drugs limited inhibitory effect parasite development high concentrations active drugs monensin halofuginone parasite multiplication high concentrations case monensin inhibition parasite development concentrations due part toxic effect drug host cells